Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Marc S. Ayers | M | - |
Romark SCS
 Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg.
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico.
Romark, L.C.
 Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | 31 ans |
| Jean-François Rossignol | M | - |
Romark SCS
Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg.
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico.
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | 31 ans |
| W. Krusen | M | 75 |
Romark SCS
Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg.
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | - |
| Celine E. Rossignol | F | - |
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | 19 ans |
| Emmet B. Keeffe | M | - |
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | - |
| Jeffrey Crowther | M | - |
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | 19 ans |
| María E. Carrión | M | - |
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | - |
| Matthew Bardin | M | - |
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 7 | 87,50% |
| Luxembourg | 3 | 37,50% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- W. Seymour Holt
- Réseau Personnel
